Impax Laboratories, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (17)

Latest Posts

About This Stock More About This Stock
3 Drug Stocks Poised To Surpass Estimates In Q2 Earnings
Article By: Zacks Investment Research
Tuesday, August 8, 2017 2:32 PM EST
The pharma/biotech sector has picked up pace this year after being battered by the drug pricing controversy in 2016. The first half has been pretty strong for companies in the space.
In this article: ALNY, IPXL, PBYI Also: JNJ, LLY, MRK, NVS, AMGN, BIIB, CELG, TEVA, ABBV
Read
AstraZeneca Enters Agreement With Grunenthal To Divest Rights To Zomig
Article By: The Fly
Wednesday, June 7, 2017 12:10 PM EST
AstraZeneca announced that it has entered an agreement with Grunenthal for the global rights to Zomig outside Japan.
In this article: AZN, IPXL
Read
Today's Stock Watch List - Friday, April 28
Article By: Ryan Mallory
Friday, April 28, 2017 12:02 PM EST
Today's stock watch list includes: CY, IPXL and CBS.
In this article: CBS, CY, IPXL
Read
Ex-CEO And Chairman Of Allergan, Paul Bisaro, Is Taking The Helm At Impax Laboratories Inc
Article By: Lorimer Wilson
Tuesday, March 28, 2017 8:14 AM EST
After handing over both the CEO and chairman reins at the company now known as Allergan longtime generics chief, Paul Bisaro, is taking the helm at Impax Laboratories Inc.
In this article: AGN, IPXL Also: NVS, TEVA, ABT, MYL
Read
Generic Drugs Probe Seen As Possible 'Severe' Sector Overhang
Article By: The Fly
Friday, November 4, 2016 1:40 PM EST
Shares of several companies believed to be involved in the probe are recouping part of yesterday's losses.
In this article: TEVA, MYL, LCI, IPXL, ENDP, TARO
Read

PARTNER HEADLINES

Latest Tweets for $IPXL

No tweets yet!